Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Pengchao Fang"'
Autor:
Xiaonan Chen, Yiqing Zou, Shuqi Zhang, Pengchao Fang, Shuxuan Li, Pengyu Li, Yingying Sun, Gang Yuan, Haiyan Hu
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 12, Iss 9, Pp 3498-3512 (2022)
Helicobacter pylori (H. pylori), creating a global infection rate over 50%, presents great challenges in clinical therapies due to its complex pathological microenvironment in vivo. To improve the eradication efficacy, herein we fabricated a pharmace
Externí odkaz:
https://doaj.org/article/92a3e0c14f6346fc9e2e3e6d969c78f4
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Glioblastoma (GBM) remains the most lethal and common primary brain tumor, even after treatment with multiple therapies, such as surgical resection, chemotherapy, and radiation. Although great advances in medical development and improvements in thera
Externí odkaz:
https://doaj.org/article/6a92fa00c2734d27854260ea1eb5eb92
Autor:
Pengchao Fang, Lu Han, Chunping Liu, Shichen Deng, E. Zhang, Puyang Gong, Yan Ren, Jian Gu, Lili He, Zhi-xiang Yuan
Publikováno v:
ACS Applied Materials & Interfaces. 14:307-323
Mesangial cell (MC)-mediated glomerulonephritis is a frequent cause of end-stage renal disease, with immune inflammatory damage and fibrosis as its basic pathological processes. However, the treatment of glomerulonephritis remains challenging owing t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6196862a688c00fe26a56033a5fc7f3e
https://doi.org/10.1021/acsami.1c20053
https://doi.org/10.1021/acsami.1c20053
Publikováno v:
Current Pharmaceutical Design. 26:1964-1978
Renal cell carcinoma (RCC) is an intractable genitourinary malignancy that accounts for approximately 4% of adult malignancies. Currently, there is no approved targeted therapy for RCC that has yielded durable remissions, and they remain palliative i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7321f95a02e543b90cfa59df81563e76
https://doi.org/10.2174/1381612826666200318153106
https://doi.org/10.2174/1381612826666200318153106
Autor:
Yiqing Zou, Xiaonan Chen, Yingying Sun, Pengyu Li, Mao Xu, Pengchao Fang, Shuqi Zhang, Gang Yuan, Xin Deng, Haiyan Hu
Publikováno v:
Journal of controlled release : official journal of the Controlled Release Society. 348
Biofilms and intracellular survival tremendously help Helicobacter pylori (H. pylori) escape from antibacterial agents attacking, therefore issuing extreme challenges to clinical therapies. Herein, we constructed fucoidan (FU)-coated nanoparticles (F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a75ce55b9ef58870ccadbde5ead54d35
https://pubmed.ncbi.nlm.nih.gov/35662575
https://pubmed.ncbi.nlm.nih.gov/35662575